Table 7.

Secondary outcome measures—underused medication (SOum)

Number	Outcomes
Underused medication
SOum-1	Patients with chronic atrial fibrillation who were not prescribed vitamin K antagonists or direct thrombin inhibitors or direct factor Xa inhibitors in the previous 12 weeks.27
SOum-2	Patients with coronary, cerebral or peripheral vascular disease who were not prescribed an antiplatelet therapy (aspirin or clopidogrel or prasugrel or ticagrelor).27
SOum-3	Patients with ischaemic heart disease who were not prescribed a beta-blocker.27
SOum-4	Patients who were prescribed methotrexate without a folic acid supplement in) the previous 12 weeks.27
SOum-5	Patients who were receiving opioids regularly without laxatives in the previous 12 weeks.27
SOum-6	Patients with systolic heart failure and/or documented coronary artery disease who were not prescribed ACE inhibitors or ARB.27
SOum-7	Patients with stable systolic heart failure who did not receive appropriate beta-blockers (bisoprolol, nebivolol, metoprolol or carvedilol).27
SOum-8	Patients not regularly taking an inhaled β2 agonist or antimuscarinic bronchodilator for mild to moderate asthma or COPD.27
SOum-9	Patients not regularly taking an inhaled corticosteroid for moderate-severe asthma or COPD.27
SOum-10	Patients with diabetes with or without serum biochemical renal impairment who did not receive ACE inhibitors or ARB (if intolerant of ACE inhibitors).27

ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.